Bio Blast Pharma Ltd. IPO Research Information

Bio Blast Pharma Ltd. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Bio Blast Pharma Ltd., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Bio Blast Pharma Ltd.	ORPN - NASDAQ	$11.00-$13.00	$11.00	$10.90	3.2 million	7/31/2014
Underwriter(s): Oppenheimer & Co., Roth Capital Partners
Co-Manager(s): BTIG
Industry: Health Care
Filing(s): Filed 2014-02-07 Underwriters Changed 2014-07-08 Terms Added 2014-07-15

Bio Blast Pharma Ltd. Quote & Chart - Click for current quote - ORPN

About Bio Blast Pharma Ltd. (adapted from Bio Blast Pharma Ltd. prospectus):
They are a development-stage biopharmaceutical company focused on the identification, licensing, acquisition, development and commercialization of drugs for rare and ultra-rare genetic diseases.

This description is adapted from Bio Blast Pharma Ltd. prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as Bio Blast Pharma Ltd. "ORPN" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.